This has been my point for some time. In Australia there are something like 5 cardiac surgeons using CardioCel yet there are 150 general
vascular surgeons who might use the patch on a regular basis but who do not presently do . Whom would you target?
Translate this figure to the developed world and we are looking at 9000 surgeons in the USA, EU and China.Where would you market your product? For 7 years for congenital heart repair or the bigger market? Go global and go for the oldies.
Centres by end of year?, page-15
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.43 |
Change
0.000(0.00%) |
Mkt cap ! $241.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90 | $11.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.30 | 90 | 1 |
View Market Depth
| Last trade - 09.49am 15/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable